Literature DB >> 20388188

A(2b) adenosine receptors can change their spots.

Michael V Cohen1, Xiulan Yang, James M Downey.   

Abstract

Recently, a central role for the A(2b) adenosine receptor in a variety of cardiovascular functions including inflammation, erectile function, coronary artery dilation, asthma and cardioprotection has been demonstrated. Despite this evidence, the low-affinity A(2b) adenosine receptor is still poorly understood. This receptor appears to be very promiscuous in its coupling. In most tissues, it couples to G(s) much like its cousin, the A(2a) adenosine receptor, but in mast cells and now, most recently, in cardiac fibroblasts, the A(2b) receptor also couples to G(q). Because of its low affinity, this receptor was originally thought unlikely to play any important physiological role. But the sensitivity of A(2b) adenosine receptors can be greatly increased by interaction with protein kinase C (PKC) making this receptor, under various conditions, both an activator and a target of PKC. We have recently documented a third coupling involving G(i). This plasticity and versatility of A(2b) adenosine receptors position them as potential triggers of signalling in multiple signalling cascades in many physiological responses, making this a most interesting receptor indeed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388188      PMCID: PMC2925483          DOI: 10.1111/j.1476-5381.2010.00668.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.

Authors:  J Linden; T Thai; H Figler; X Jin; A S Robeva
Journal:  Mol Pharmacol       Date:  1999-10       Impact factor: 4.436

2.  Altered expression of adenosine receptors in heart of diabetic rat.

Authors:  M Grdeń; M Podgórska; A Szutowicz; T Pawełczyk
Journal:  J Physiol Pharmacol       Date:  2005-12       Impact factor: 3.011

3.  Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.

Authors:  Nataliya V Solenkova; Viktoriya Solodushko; Michael V Cohen; James M Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-09       Impact factor: 4.733

Review 4.  Adenosine A2B receptors.

Authors:  I Feoktistov; I Biaggioni
Journal:  Pharmacol Rev       Date:  1997-12       Impact factor: 25.468

5.  Characterization of a stimulatory adenosine A2a receptor in adult rat ventricular myocyte.

Authors:  H Xu; B Stein; B Liang
Journal:  Am J Physiol       Date:  1996-05

Review 6.  Adenosine, adenosine receptors and myocardial protection: an updated overview.

Authors:  K Mubagwa; W Flameng
Journal:  Cardiovasc Res       Date:  2001-10       Impact factor: 10.787

7.  Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

Authors:  G S Liu; J Thornton; D M Van Winkle; A W Stanley; R A Olsson; J M Downey
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

8.  Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors.

Authors:  R Ray Morrison; M A Hassan Talukder; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

Review 9.  Signalling from adenosine receptors to mitogen-activated protein kinases.

Authors:  Gunnar Schulte; Bertil B Fredholm
Journal:  Cell Signal       Date:  2003-09       Impact factor: 4.315

10.  Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.

Authors:  B T Liang; B Haltiwanger
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

View more
  10 in total

Review 1.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

Review 2.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

3.  Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2017-12-18       Impact factor: 4.432

4.  Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits.

Authors:  Jan Hendrik Voss; Andhika B Mahardhika; Asuka Inoue; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-03

5.  Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.

Authors:  Raghvendra K Dubey; Jürgen Fingerle; Delbert G Gillespie; Zaichuan Mi; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson
Journal:  Hypertension       Date:  2015-09-28       Impact factor: 10.190

Review 6.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

7.  IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.

Authors:  Xiaoyang Hua; Kelly D Chason; Janki Y Patel; Warren C Naselsky; Stephen L Tilley
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

8.  A2BR adenosine receptor modulates sweet taste in circumvallate taste buds.

Authors:  Shinji Kataoka; Arian Baquero; Dan Yang; Nicole Shultz; Aurelie Vandenbeuch; Katya Ravid; Sue C Kinnamon; Thomas E Finger
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

Review 9.  Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis.

Authors:  Elizabeth A Vecchio; Paul J White; Lauren T May
Journal:  Front Pharmacol       Date:  2017-05-05       Impact factor: 5.810

Review 10.  Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.

Authors:  Wiwin Is Effendi; Tatsuya Nagano; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Cells       Date:  2020-03-24       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.